These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15710389)

  • 1. Small Jab1-containing subcomplex is regulated in an anchorage- and cell cycle-dependent manner, which is abrogated by ras transformation.
    Fukumoto A; Tomoda K; Kubota M; Kato JY; Yoneda-Kato N
    FEBS Lett; 2005 Feb; 579(5):1047-54. PubMed ID: 15710389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression.
    Tomoda K; Kato JY; Tatsumi E; Takahashi T; Matsuo Y; Yoneda-Kato N
    Blood; 2005 Jan; 105(2):775-83. PubMed ID: 15353483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif.
    Burger-Kentischer A; Finkelmeier D; Thiele M; Schmucker J; Geiger G; Tovar GE; Bernhagen J
    FEBS Lett; 2005 Mar; 579(7):1693-701. PubMed ID: 15757663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells.
    Hsu MC; Chang HC; Hung WC
    Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.
    Jeon JH; Lee KN; Hwang CY; Kwon KS; You KH; Choi I
    Cancer Res; 2005 Jun; 65(11):4485-9. PubMed ID: 15930262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple functions of Jab1 are required for early embryonic development and growth potential in mice.
    Tomoda K; Yoneda-Kato N; Fukumoto A; Yamanaka S; Kato JY
    J Biol Chem; 2004 Oct; 279(41):43013-8. PubMed ID: 15299027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAB1/CSN5 and the COP9 signalosome. A complex situation.
    Chamovitz DA; Segal D
    EMBO Rep; 2001 Feb; 2(2):96-101. PubMed ID: 11258719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSN5/Jab1 controls multiple events in the mammalian cell cycle.
    Yoshida A; Yoneda-Kato N; Panattoni M; Pardi R; Kato JY
    FEBS Lett; 2010 Nov; 584(22):4545-52. PubMed ID: 20974137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic investigation on the development of molecular targeting therapy against cyclin-dependent kinase inhibitor p27Kip1 in head and neck cancer cells.
    Supriatno ; Harada K; Yoshida H; Sato M
    Int J Oncol; 2005 Sep; 27(3):627-35. PubMed ID: 16077910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1.
    Tanaka Y; Kanai F; Ichimura T; Tateishi K; Asaoka Y; Guleng B; Jazag A; Ohta M; Imamura J; Ikenoue T; Ijichi H; Kawabe T; Isobe T; Omata M
    Oncogene; 2006 Jan; 25(4):633-42. PubMed ID: 16247477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
    Schepers H; Wierenga AT; Eggen BJ; Vellenga E
    Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo.
    Hsu MC; Huang CC; Chang HC; Hu TH; Hung WC
    Clin Cancer Res; 2008 Jul; 14(13):4045-52. PubMed ID: 18593980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
    Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J
    Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of Jab1 inhibits proliferation of pancreatic cancer cell lines.
    Fukumoto A; Tomoda K; Yoneda-Kato N; Nakajima Y; Kato JY
    FEBS Lett; 2006 Oct; 580(25):5836-44. PubMed ID: 17027978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adapter protein NRBP associates with Jab1 and negatively regulates AP-1 activity.
    Wang H; Sun X; Luo Y; Lin Z; Wu J
    FEBS Lett; 2006 Oct; 580(25):6015-21. PubMed ID: 17052710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock transcription factor (Hsf)-4b recruits Brg1 during the G1 phase of the cell cycle and regulates the expression of heat shock proteins.
    Tu N; Hu Y; Mivechi NF
    J Cell Biochem; 2006 Aug; 98(6):1528-42. PubMed ID: 16552721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis.
    Duran A; Linares JF; Galvez AS; Wikenheiser K; Flores JM; Diaz-Meco MT; Moscat J
    Cancer Cell; 2008 Apr; 13(4):343-54. PubMed ID: 18394557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The COP9 signalosome: more than a protease.
    Wei N; Serino G; Deng XW
    Trends Biochem Sci; 2008 Dec; 33(12):592-600. PubMed ID: 18926707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jab1 mediates protein degradation of the Rad9-Rad1-Hus1 checkpoint complex.
    Huang J; Yuan H; Lu C; Liu X; Cao X; Wan M
    J Mol Biol; 2007 Aug; 371(2):514-27. PubMed ID: 17583730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuronal POU transcription factor Brn-2 interacts with Jab1, a gene involved in the onset of neurodegenerative diseases.
    Huang YT; Iwamoto K; Kurosaki T; Nasu M; Ueda S
    Neurosci Lett; 2005 Jul 1-8; 382(1-2):175-8. PubMed ID: 15911144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.